NCT00514059View on ClinicalTrials.gov

Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

June 30, 2007

Conditions
DiphtheriaTetanusPertussisPolio
Interventions
DRUG

Boostrix polio

1 dose (0.5 ml) i.m.

Trial Locations (1)

Unknown

Norwegian Institute of Public Health, Oslo

All Listed Sponsors
lead

Norwegian Institute of Public Health

OTHER_GOV

NCT00514059 - Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine | Biotech Hunter | Biotech Hunter